GB201322451D0 - Purification method and compositions - Google Patents

Purification method and compositions

Info

Publication number
GB201322451D0
GB201322451D0 GBGB1322451.4A GB201322451A GB201322451D0 GB 201322451 D0 GB201322451 D0 GB 201322451D0 GB 201322451 A GB201322451 A GB 201322451A GB 201322451 D0 GB201322451 D0 GB 201322451D0
Authority
GB
United Kingdom
Prior art keywords
compositions
purification method
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1322451.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB1322451.4A priority Critical patent/GB201322451D0/en
Publication of GB201322451D0 publication Critical patent/GB201322451D0/en
Priority to PCT/EP2014/078608 priority patent/WO2015091881A1/en
Priority to EP14815726.6A priority patent/EP3083526B1/en
Priority to ES14815726T priority patent/ES2750624T3/es
Priority to HK16114397.2A priority patent/HK1226050B/zh
Priority to JP2016539182A priority patent/JP6842920B2/ja
Priority to CN201480069376.6A priority patent/CN105849067B/zh
Priority to US15/102,511 priority patent/US20160303262A1/en
Priority to JP2019108641A priority patent/JP2019196356A/ja
Priority to US17/314,158 priority patent/US20210330824A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/22—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the construction of the column
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
GBGB1322451.4A 2013-12-18 2013-12-18 Purification method and compositions Ceased GB201322451D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1322451.4A GB201322451D0 (en) 2013-12-18 2013-12-18 Purification method and compositions
US15/102,511 US20160303262A1 (en) 2013-12-18 2014-12-18 Purification method and compositions
HK16114397.2A HK1226050B (zh) 2013-12-18 2014-12-18 纯化方法和组合物
EP14815726.6A EP3083526B1 (en) 2013-12-18 2014-12-18 Purification method and compositions
ES14815726T ES2750624T3 (es) 2013-12-18 2014-12-18 Método de purificación y composiciones
PCT/EP2014/078608 WO2015091881A1 (en) 2013-12-18 2014-12-18 Purification method and compositions
JP2016539182A JP6842920B2 (ja) 2013-12-18 2014-12-18 精製方法及び組成物
CN201480069376.6A CN105849067B (zh) 2013-12-18 2014-12-18 纯化方法和组合物
JP2019108641A JP2019196356A (ja) 2013-12-18 2019-06-11 精製方法及び組成物
US17/314,158 US20210330824A1 (en) 2013-12-18 2021-05-07 Purification method and compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1322451.4A GB201322451D0 (en) 2013-12-18 2013-12-18 Purification method and compositions

Publications (1)

Publication Number Publication Date
GB201322451D0 true GB201322451D0 (en) 2014-02-05

Family

ID=50071048

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1322451.4A Ceased GB201322451D0 (en) 2013-12-18 2013-12-18 Purification method and compositions

Country Status (8)

Country Link
US (2) US20160303262A1 (cg-RX-API-DMAC7.html)
EP (1) EP3083526B1 (cg-RX-API-DMAC7.html)
JP (2) JP6842920B2 (cg-RX-API-DMAC7.html)
CN (1) CN105849067B (cg-RX-API-DMAC7.html)
ES (1) ES2750624T3 (cg-RX-API-DMAC7.html)
GB (1) GB201322451D0 (cg-RX-API-DMAC7.html)
HK (1) HK1226050B (cg-RX-API-DMAC7.html)
WO (1) WO2015091881A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120165650A1 (en) * 2010-12-22 2012-06-28 General Electric Company Her2 binders
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
US20210350946A1 (en) * 2019-10-25 2021-11-11 ITM Isotopen Technologien München AG System and method of recovering a parent radionuclide from a radionuclide generator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2119458B9 (en) * 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
CA2819347A1 (en) * 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
GB201020314D0 (en) * 2010-12-01 2011-01-12 Ge Healthcare Ltd Apoptosis pet imaging agents
NZ612327A (en) * 2010-12-22 2015-03-27 Ge Healthcare Ltd Her2 binding peptides labelled with a 18f - containing organosilicon compound
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method

Also Published As

Publication number Publication date
EP3083526A1 (en) 2016-10-26
JP2019196356A (ja) 2019-11-14
JP6842920B2 (ja) 2021-03-17
HK1226050B (zh) 2017-09-22
US20160303262A1 (en) 2016-10-20
EP3083526B1 (en) 2019-08-07
JP2017501152A (ja) 2017-01-12
US20210330824A1 (en) 2021-10-28
ES2750624T3 (es) 2020-03-26
CN105849067B (zh) 2018-04-17
CN105849067A (zh) 2016-08-10
WO2015091881A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
IL273205A (en) Preparations and methods
GB2520795B (en) Compositions and methods
SMT201900635T1 (it) Composizioni e metodi di attivazione della segnalazione dipendente dallo "stimolatore di geni interferone"
GB201308072D0 (en) Compositions and methods
GB201305414D0 (en) Method and composition
GB201312318D0 (en) Novel methods and compounds
GB201305813D0 (en) Compositions and methods
IL239680A0 (en) Preparations and methods for polynucleotide transfection
GB201300376D0 (en) Method and compound
EP2964610A4 (en) VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
IL244026B (en) wnt preparations and purification methods
ZA201604113B (en) Siliceous composition and method for obtaining same
GB201300409D0 (en) Method
GB201305714D0 (en) Method
SG11201601264UA (en) Soil-volume reduction method
GB201314581D0 (en) Purification
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods
ZA201500493B (en) Glycoconjugation processes and compositions
GB201315291D0 (en) Compound and method
GB201315296D0 (en) Compound and method
GB201315289D0 (en) Compound and method
GB201315300D0 (en) Compound and Method
GB201315295D0 (en) Compound and method
GB201315292D0 (en) Compound and method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)